Impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer

被引：0
|
作者：
Fowble, B.
Fein, D.A.
Hanlon, A.L.
Eisenberg, B.L.
Hoffman, J.P.
Sigurdson, E.R.
Daly, M.B
Goldstein, L.J.
机构：
来源：
International Journal of Radiation Oncology, Biology, Physics | 1996年 / 35卷 / 04期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer
    Fowble, B
    Fein, DA
    Hanlon, AL
    Eisenberg, BL
    Hoffman, JP
    Sigurdson, ER
    Daly, MB
    Goldstein, LJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (04): : 669 - 677
  • [2] Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer
    Dignam, JJ
    Wieand, K
    Johnson, KA
    Fisher, B
    Xu, L
    Mamounas, EP
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19): : 1467 - 1476
  • [3] Incorporating immunotherapy in the management of early-stage estrogen receptor-positive breast cancer
    Nader-Marta, G.
    Waks, A. G.
    Tolaney, S. M.
    Mayer, E. L.
    ESMO OPEN, 2024, 9 (11)
  • [4] Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
    Criscitiello, Carmen
    Fumagalli, Debora
    Saini, Kamal S.
    Loi, Sherene
    ONCOTARGETS AND THERAPY, 2011, 4 : 1 - 11
  • [5] Pharmacoeconomic analysis of exemestane versus tamoxifen as adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer
    Gil, JM
    Lluch, A
    González, P
    Del Castillo, A
    Canorea, F
    Rubio-Terrés, C
    VALUE IN HEALTH, 2005, 8 (06) : A37 - A38
  • [6] Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
    Zhang, Yi
    Schnabel, Catherine A.
    Schroeder, Brock E.
    Jerevall, Piiha-Lotta
    Jankowitz, Rachel C.
    Fornander, Tommy
    Stal, Olle
    Brufsky, Adam M.
    Sgroi, Dennis
    Erlander, Mark G.
    CLINICAL CANCER RESEARCH, 2013, 19 (15) : 4196 - 4205
  • [7] Treatment of Early-Stage Hormone Receptor-Positive Breast Cancer
    Rugo, Hope S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 596 - 599
  • [8] Societal economics of the 21-gene Recurrence Score® in estrogen receptor-positive early-stage breast cancer in Japan
    Yamauchi, H.
    Nakagawa, C.
    Yamashige, S.
    Takei, H.
    Yagata, H.
    Yoshida, A.
    Hayashi, N.
    Hornberger, J.
    Yu, T.
    Chien, R.
    Chao, C.
    Yoshizawa, C.
    Nakamura, S.
    CANCER RESEARCH, 2012, 72
  • [9] Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor-Positive Breast Cancer: Clinical Versus Molecular Tools
    Foldi, Julia
    O'Meara, Tess
    Marczyk, Michal
    Sanft, Tara
    Silber, Andrea
    Pusztai, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (16) : 1365 - +
  • [10] Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women
    Nayyar, Apoorve
    Strassle, Paula D.
    Iles, Kathleen
    Jameison, Danielle
    Jadi, Jihane
    McGuire, Kandace P.
    Gallagher, Kristalyn K.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (12) : 4853 - 4860
12345